Caxton Associates (New York)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-657
| Closed | -$323K | – | 583 |
|
|
2022
Q1 | $323K | Buy |
+657
| New | +$323K | 0.03% | 319 |
|
|
2021
Q4 | – | Sell |
-1,693
| Closed | -$631K | – | 555 |
|
|
2021
Q3 | $631K | Buy |
+1,693
| New | +$631K | 0.07% | 144 |
|
|
2020
Q4 | – | Sell |
-1,595
| Closed | -$428K | – | 164 |
|
|
2020
Q3 | $428K | Buy |
1,595
+474
| +42% | +$127K | 0.05% | 121 |
|
|
2020
Q2 | $295K | Buy |
+1,121
| New | +$295K | 0.03% | 249 |
|
|
2019
Q4 | – | Sell |
-2,923
| Closed | -$702K | – | 426 |
|
|
2019
Q3 | $702K | Buy |
+2,923
| New | +$702K | 0.14% | 74 |
|
|
2019
Q2 | – | Sell |
-1,853
| Closed | -$532K | – | 415 |
|
|
2019
Q1 | $532K | Buy |
+1,853
| New | +$532K | 0.08% | 129 |
|
|
2018
Q2 | – | Sell |
-1,901
| Closed | -$418K | – | 358 |
|
|
2018
Q1 | $418K | Buy |
+1,901
| New | +$418K | 0.02% | 234 |
|
|
2017
Q4 | – | Sell |
-3,100
| Closed | -$589K | – | 330 |
|
|
2017
Q3 | $589K | Buy |
+3,100
| New | +$589K | 0.02% | 230 |
|